A patient with Simpson-Golabi-Behmel syndrome, biliary cirrhosis and successful liver transplantation

• Published in: American journal of medical genetics. Part A Vol. 164A; no. 3; pp. 774 - 777
• Main Authors: Jedraszak, Guillaume, Girard, Muriel, Mellos, Antonio, Djeddi, Djamal-Dine, Chardot, Christophe, Vanrenterghem, Audrey, Moizard, Marie-Pierre, Gondry, Jean, Sevestre, Henri, Mathieu-Dramard, Michele, Lacaille, Florence, Demeer, Benedicte
• Format: Journal Article
• Language: English
• Published: United States Blackwell Publishing Ltd 01.03.2014; Wiley Subscription Services, Inc
• Subjects: Age; Arrhythmias, Cardiac - diagnosis; Arrhythmias, Cardiac - genetics; Arrhythmias, Cardiac - therapy; biliary cirrhosis; Biopsy; Genetic Diseases, X-Linked - diagnosis; Genetic Diseases, X-Linked - genetics; Genetic Diseases, X-Linked - therapy; Gigantism - diagnosis; Gigantism - genetics; Gigantism - therapy; Glypicans - genetics; GPC3; Heart Defects, Congenital - diagnosis; Heart Defects, Congenital - genetics; Heart Defects, Congenital - therapy; Humans; Infant; Intellectual Disability - diagnosis; Intellectual Disability - genetics; Intellectual Disability - therapy; Liver - pathology; Liver Cirrhosis, Biliary - diagnosis; Liver Cirrhosis, Biliary - genetics; Liver Cirrhosis, Biliary - therapy; Liver Transplantation; Male; Mutation; Phenotype; Simpson-Golabi-Behmel syndrome; Treatment Outcome; Simpson-Golabi-Behmel syndrome; GPC3; biliary cirrhosis; liver transplantation
• ISSN: 1552-4825; 1552-4833
• DOI: 10.1002/ajmg.a.36335

ABSTRACT Simpson–Golabi–Behmel syndrome type 1 (SGBS1) ‐OMIM 312870‐ is a rare X‐linked inherited overgrowth syndrome caused by a loss of function mutation in the GPC3 gene. Affected patients present a variable phenotype with pre‐ and post‐natal macrosomia, distinctive facial dysmophism, organomegaly, and multiple congenital anomalies. Intellectual disability is not constant. About 10% of patients have an increased risk of developing embryonic tumors in early childhood. Only one case of biliary disease has been described so far. GPC3 is localized on Xq26. It encodes for glypican 3, a heparan sulfate proteoglycan, which among its different known roles, negatively regulates liver regeneration and hepatocyte proliferation. This report concerns a male with a SGBS1, carrier of a GPC3 pathogenic mutation, and neonatal liver disease, who developed an early biliary cirrhosis. Together with the associated risk of cancer and developmental delay, liver transplantation was discussed and then successfully performed at the age of 19 months. A hypothesis on the role of GPC3 in the patient's liver disease is also proposed. © 2013 Wiley Periodicals, Inc.